Literature DB >> 9566837

Protein kinase C alterations in aortic vascular smooth muscle cells from rats with cirrhosis.

C Trombino1, K A Tazi, A Gadano, R Moreau, D Lebrec.   

Abstract

BACKGROUND/AIMS: Alterations in signal transduction in vascular smooth muscle cells may contribute to vascular hyporeactivity in cirrhosis. Protein kinase C plays a role in vascular cell contraction by modifying contractile proteins and intracellular [Ca2+] homeostasis. The aim of this study was to examine the vascular reactivity and expression of protein kinase Calpha in aortae from rats with cirrhosis.
METHODS: The contractile response to phorbol ester, a protein kinase C activator, was evaluated in endothelium-denuded aortic rings from normal and cirrhotic rats. Protein kinase Calpha expression was determined by Western blot analysis.
RESULTS: Maximal contraction was significantly less marked in cirrhotic (1.24+/-0.24 g) than in control (3.43+/-0.27 g) aortae. Phorbol myristate-acetate-induced contraction was dependent on extracellular [Ca2+] concentrations, as shown by a reduction in maximal contraction when control and cirrhotic aortic rings were exposed to a Ca2+-free medium. Increasing the intracellular [Ca2+], by incubation with a Ca2+ ionophore, significantly increased the maximal contraction induced by phorbol myristate-acetate in cirrhotic but not in control rat aortae. Protein kinase Calpha expression was significantly lower in aortae in cirrhotic than in control rats.
CONCLUSION: These results confirm alterations in protein kinase C in aortae from cirrhotic rats.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566837     DOI: 10.1016/s0168-8278(98)80292-4

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  2 in total

1.  Vascular contractile response and signal transduction in endothelium-denuded aorta from cirrhotic rats.

Authors:  Han-Chieh Lin; Ying-Ying Yang; Yi-Tsau Huang; Tzung-Yan Lee; Ming-Chih Hou; Fa-Yauh Lee; Shou-Dong Lee
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

2.  Renal dysfunction in patients with chronic liver disease.

Authors:  Jay Wook Lee
Journal:  Electrolyte Blood Press       Date:  2009-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.